A method of reducing drug-induced adverse side effects in a patient

Details for Australian Patent Application No. 2005295888 (hide)

Owner Intercept Pharmaceuticals Inc.

Inventors Fiorucci, Stefano; Pruzanski, Mark; Pellicciari, Roberto

Agent Spruson & Ferguson

Pub. Number AU-A-2005295888

PCT Pub. Number WO2006/044391

Priority 60/619,381 14.10.04 US

Filing date 14 October 2005

Wipo publication date 27 April 2006

International Classifications

A61K 38/28 (2006.01) Medicinal preparations containing peptides - Insulins

A61K 31/155 (2006.01) - Amidines (), e.g. guanidine (HNC(NH)NH), isourea (HNC(OH)NH), isothiourea (HNC(SH)NH)

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 31/425 (2006.01) - Thiazoles

Event Publications

17 May 2007 PCT application entered the National Phase

  PCT publication WO2006/044391 Priority application(s): WO2006/044391

12 May 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005295890-Shaped plant growth nutrient products and processes for the production thereof

2005295884-Fluid pump